SANTOS CARLOS E (Chief Financial Officer) sold 27.6% of their position (5.43K shares) of LEGEND BIOTECH CORP on the open market
Open‑market sale worth $49.6K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/23/2026ACC: 0002097065-26-000005
Officer· Chief Financial Officer
Since Mar 2026
+14.25K
Net shares
Net buyer
$49.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
19.68K acquired · 5.43K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+19.68K
Price / share
—
Trade value
—
% of position
New position
9/21/2026
0.00→19.68K
Ordinary Shares
Direct
Shares
−5.43K
Price / share
$9.14
Trade value
$49.63K
% of position
27.6%
9/21/2026
19.68K→14.25K
Total
Net shares
+14.25K
Net value
-$49.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/21/2026 | A · Award | +19.68K | — | — | New position | 0.00 | 19.68K |
| Ordinary Shares Direct | 9/21/2026 | S · Sale | −5.43K | $9.14 | $49.63K | 27.6% | 19.68K | 14.25K |
| Total | +14.25K | -$49.63K | ||||||
Derivative Transactions0
No derivative transactions reported